1 이경훈, "The Significance of Clopidogrel Low-Responsiveness on Stent Thrombosis and Cardiac Death Assessed by the Verifynow P2Y12 Assay in Patients With Acute Coronary Syndrome Within 6 Months After Drug-Eluting Stent Implantation" 대한심장학회 39 (39): 512-518, 2009
2 Muir DF, "Recurrent stent thrombosis associated with lupus anticoagulant due to renal cell carcinoma" 5 : 44-46, 2003
3 Roman MJ, "Prevalence and correlates of accelerated atherosclerosis in systemic lupus erythematosus" 349 : 2399-2406, 2003
4 Kassaian S, "Myocardial infarction secondary to premature coronary artery disease as the initial major manifestation of systemic lupus erythematous" 19 : 152-154, 2008
5 Cervera R, "Morbidity and mortality in systemic lupus erythematosus during a 10-year period: a comparison of early and late manifestations in a cohort of 1,000 patients" 82 : 299-308, 2003
6 Lee CH, "Long-term follow-up after percutaneous coronary intervention in patients with systemic lupus erythematous" 126 : 430-432, 2008
7 Olivier AC, "Late in-stent thrombosis in a patient with systemic lupus erythematosus and hyperhomocysteinemia while on clopidogrel and aspirin" 18 : E185-E187, 2006
8 Lee CW, "Intravascular ultrasound findings in patients with very late stent thrombosis after either drug-eluting or bare-metal stent implantation" 55 : 1943-1944, 2010
9 Lee CH, "Dilemma of drug-eluting stent implantation in a patient with systemic lupus erythematosus" 114 : e107-e108, 2007
10 Haider YS, "Coronary arterial disease in systemic lupus erythematous: quantification of degree of narrowing in 22 necropsy patients (21 women) aged 16 to 37 years" 70 : 775-781, 1981
1 이경훈, "The Significance of Clopidogrel Low-Responsiveness on Stent Thrombosis and Cardiac Death Assessed by the Verifynow P2Y12 Assay in Patients With Acute Coronary Syndrome Within 6 Months After Drug-Eluting Stent Implantation" 대한심장학회 39 (39): 512-518, 2009
2 Muir DF, "Recurrent stent thrombosis associated with lupus anticoagulant due to renal cell carcinoma" 5 : 44-46, 2003
3 Roman MJ, "Prevalence and correlates of accelerated atherosclerosis in systemic lupus erythematosus" 349 : 2399-2406, 2003
4 Kassaian S, "Myocardial infarction secondary to premature coronary artery disease as the initial major manifestation of systemic lupus erythematous" 19 : 152-154, 2008
5 Cervera R, "Morbidity and mortality in systemic lupus erythematosus during a 10-year period: a comparison of early and late manifestations in a cohort of 1,000 patients" 82 : 299-308, 2003
6 Lee CH, "Long-term follow-up after percutaneous coronary intervention in patients with systemic lupus erythematous" 126 : 430-432, 2008
7 Olivier AC, "Late in-stent thrombosis in a patient with systemic lupus erythematosus and hyperhomocysteinemia while on clopidogrel and aspirin" 18 : E185-E187, 2006
8 Lee CW, "Intravascular ultrasound findings in patients with very late stent thrombosis after either drug-eluting or bare-metal stent implantation" 55 : 1943-1944, 2010
9 Lee CH, "Dilemma of drug-eluting stent implantation in a patient with systemic lupus erythematosus" 114 : e107-e108, 2007
10 Haider YS, "Coronary arterial disease in systemic lupus erythematous: quantification of degree of narrowing in 22 necropsy patients (21 women) aged 16 to 37 years" 70 : 775-781, 1981
11 Su HM, "Acute thrombosis after elective direct intracoronary stenting in primary antiphospholipid syndrome: a case report" 19 : 177-182, 2003
12 Metha PK, "Acute coronary syndrome as a first presentation of systemic lupus erythematosus in a teenager: revascularization by hybrid coronary artery bypass graft surgery and percutaneous coronary intervention: case report" 29 : 957-961, 2008
13 Moon YG, "A case of premature coronary atherosclerosis associated with systemic lupus erythematosus" 25 : 691-697, 1995